Nuveen Asset Management, LLC Beyond Spring Inc. Transaction History

Nuveen Asset Management, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$1.13 - $2.66 $226,766 - $533,803	-200,678 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$1.68 - $5.01 $922 - $2,750	549 Added 0.27%	200,678 $2.56 Million
Q4 2021 Feb 14, 2022	BUY	$4.02 - $16.84 $31,766 - $133,069	7,902 Added 4.11%	200,129 $2.56 Million
Q3 2021 Nov 12, 2021	BUY	$9.26 - $31.31 $543,478 - $1.84 Million	58,691 Added 43.95%	192,227 $1.85 Million
Q2 2021 Aug 16, 2021	SELL	$9.37 - $12.12 $378,529 - $489,623	-40,398 Reduced 23.23%	133,536 $1.4 Million
Q1 2021 May 17, 2021	BUY	$10.61 - $15.77 $566,489 - $841,991	53,392 Added 44.29%	173,934 $1.93 Million
Q4 2020 Feb 16, 2021	BUY	$10.21 - $17.31 $890,097 - $1.51 Million	87,179 Added 261.3%	120,542 $1.47 Million
Q2 2020 Aug 14, 2020	BUY	$11.21 - $18.15 $373,999 - $605,538	33,363 New	33,363 $503,000

5.55M

26K

2.4K

Ticker BYSI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 38,928,900
Market Cap $66.6M
Description
BeyondSpring Inc., a clinical stage biopharmaceutical company, together with its subsidiaries, focuses on the development of cancer therapies. The company's lead asset is the Plinabulin, a selective immune-modulating microtubule-binding agent that has completed Phase III clinical trials for the prevention of chemotherapy-induced neutropenia; and...

Get notified when there are updates to the investment portfolio of Nuveen Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Nuveen Asset Management, LLC with notifications on news.